Aimei Health Q2 FY26 net loss widens to $83,144; six-month net loss totals $37,704

• Aimei Health posted a net loss of USD 83,144 for the quarter ended June 30, 2026, versus net income of USD 424,970 a year earlier.
• General and administrative costs rose to USD 192,348, while interest income from the trust account fell to USD 109,204.
• For the six months ended June 30, 2026, net loss totaled USD 37,704, compared with net income of USD 609,632 a year earlier.
• Cash outside the trust account was USD 1,466, with USD 12.49 million held in the trust account and a working capital deficit of about USD 3.79 million.
• Terminated its United Hydrogen merger agreement on July 7, 2026 after CSRC approval had not been granted as of July 6, 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aimei Health Technology Co. Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-037588), on August 13, 2026, and is solely responsible for the information contained therein.